Chloe Sligar
@ChloeSligar
Followers
194
Following
938
Media
43
Statuses
123
Science Goblin 👩🏼🔬👹| University of Wollongong | Molecular Horizons | Immunologist turned Neuroscientist 🦠 🧠
New South Wales, Australia
Joined August 2019
Certified Poindexter 🤓 A massive thank you to my supervisors Prof Ronald Sluyter and Dr Debbie Watson for their knowledge, guidance and support over the last 5 years 🧪 🐭 @drdebbiew2
0
0
1
🚨 Excited to share our latest protocol utilising bioluminescent leukaemia cells to establish a humanised mouse model of graft-versus-leukemia immunity; allowing for real-time in vivo tracking of leukaemia burden 🧬🐭 #LeukemiaResearch #GVHD
https://t.co/XMQ7taCs5i
link.springer.com
Humanized mouse models of graft-versus-host disease (GVHD) primarily focus on treatments to prevent disease progression. However, there is little investigation into whether graft-versus-leukemia...
0
1
4
Accidentally played matchy-matchy with my poster last week at #ASI2024. It was lovely catching up with my fellow nerds 🤓and presenting the final chapter from my PhD 🧪👩🏼🔬
0
0
16
The slog is almost over 😎
Seminar today at 12.30pm in 32-G01 or online! Join us for Chloe Sligar's PhD exit seminar titled 'Combination Therapies to Prevent Graft-versus-Host Disease' https://t.co/SbrYjI814q
@uowresearch
#MHSeminarSeries
1
0
11
My latest 1st-author paper is live 🤩✨ Published in CTI, Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice https://t.co/gwmpDZXIYw Shout out to all of my lovely co-authors!
onlinelibrary.wiley.com
Donor haematopoietic stem cell transplantation treats leukaemia by inducing graft-versus-leukaemia (GVL) immunity. However, this benefit is often mitigated by graft-versus-host disease (GVHD), which...
0
0
8
Our team (the Zesty Zebrafish 🐠) are swimming 100km over the month of March in Cure Cancer’s Swim for a CURE fundraiser where every stroke counts in the mission to help fund vital cancer research. Link below if you’d like to sponsor us! https://t.co/Pbw0P5uXBw
curecancer.com.au
0
1
7
🕵🏽♂️Why do some B cells live longer than others? @Jessemulder98 gave us the inside scoop with his fabulous talk at #ASI2023NZ 🤩 🐁 🧪 @ASImmunology
0
1
8
One of my supervisors, Prof Ronald Sluyter, showing off some work from his lab carried out by Ross Turner about immune cell signatures associated with relapse free survival in head and neck cancer at #ASI2023NZ @ASImmunology
0
1
13
Excited to be presenting our research on graft-versus-host disease and graft-versus-leukaemia at the national immunology meeting. Posters from myself and my two PhD students Chloe and Amal #ASI2023NZ
0
3
16
Really nice talk from Prof Scott Byrne @photoimmunology at #ASI2023NZ about his labs work on a new topical peptide to treat inflammatory skin diseases like psoriasis 🤩 very cool stuff @ASImmunology
0
2
12
THIS SUMMER Matthew McConaughey stars in ... The PhD A poorly funded project that took years to finish
12
82
777
💪 😎
Congrats to my PhD student Chloe Sligar for winning HDR Best Student Poster Award at the MH Symposium today 👩🏻🔬🧬🔬😎
0
0
9
He’s up there pushing electrons and I have no idea what’s going on, but it was a pleasure watching my organic chemist pal give his PhD exit seminar today 🤩⚛️ 🧪 Congrats on finishing your PhD Philip!
0
0
9
Was so busy hyping up the rest of the team that I forgot to hype myself up 🤪 Had another opportunity to present some of my PhD work on a combination therapy to prevent GVHD while preserving GVL immunity at the ASI NSW/ACT branch meeting in Bowral @ASImmunology
0
1
7
Lab homie Amal strikes again with a presentation on her recently published work using a species-specific antibody targeting P2X7 to treat GVHD in humanised mice 🐭 at the @ASImmunology ACT/NSW branch meeting. Out flying the Sluyter flag 🏳️
0
1
7
✨✨✨Huge congrats to lab homie Amal on the publication of her P2Xcellent first 1st author paper: A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice 🐭 https://t.co/DdRgizlKYK
#mdpipharmaceutics via @MDPIpharma
mdpi.com
Graft-versus-host disease (GVHD) is a T cell-mediated inflammatory disorder that arises from allogeneic haematopoietic stem cell transplantation and is often fatal. The P2X7 receptor is an extracel...
0
1
5